Group 2: single-dose of reference formulation+single-dose of test formulation
Sponsors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Conditions
Thrombocytopenia
Unknown Phase
Bioequivalence Study of Eltrombopag Olamine Tablets in Healthy Subjects in the Fed State
CompletedNCT06768619
Start: 2023-03-20End: 2023-04-27Updated: 2025-12-16
Bioequivalence Test of Eltrombopag Olamine Tablets in Humans Under Fasting State
CompletedNCT06768632
Start: 2020-01-02End: 2023-12-30Updated: 2025-01-10